Achillion Pharmaceuticals, Inc (NASDAQ:ACHN) Director Gary E. Frashier unloaded 55,000 shares of the stock on the open market in a transaction that occurred on Monday, June 16th. The shares were sold at an average price of $8.00, for a total transaction of $440,000.00. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was -3.07% in last session and finished the day at $7.58. Traded volume was 13.15million shares in the last session and the average volume of the stock remained 4.69million shares. The beta of the stock remained 1.89. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) insider ownership is 13.04%.

MannKind Corporation (NASDAQ:MNKD) VP Diane Palumbo unloaded 17,902 shares of the company’s stock on the open market in a transaction dated Monday, June 16th. The stock was sold at an average price of $10.59, for a total transaction of $189,582.18. Following the completion of the transaction, the vice president now directly owns 140,956 shares in the company, valued at approximately $1,492,724. MannKind Corporation (NASDAQ:MNKD) dropped -0.47 percent to $10.60 Tuesday on volume of 6.58million shares. The intra-day range of the stock was $10.51 to $10.75. MannKind Corporation (NASDAQ:MNKD) has a market capitalization of $4.12billion.

Questcor Pharmaceuticals Inc (NASDAQ:QCOR) CEO Don M. Bailey sold 40,000 shares of Questcor Pharmaceuticals stock on the open market in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $89.83, for a total value of $3,593,200.00. Questcor Pharmaceuticals Inc (NASDAQ:QCOR)’s stock on June 17, 2014 reported a increase of 2.86% to the closing price of $91.11. Its fifty two weeks range is $42.01 -$94.20. The total market capitalization recorded $5.56billion. The overall volume in the last trading session was 1.40million shares. In its share capital, QCOR has 60.98million outstanding shares.

Dyax Corp. (NASDAQ:DYAX) CFO George V. Migausky unloaded 16,000 shares of Dyax Corp. stock in a transaction that occurred on Friday, June 13th. The stock was sold at an average price of $8.26, for a total transaction of $132,160.00. Following the transaction, the chief financial officer now directly owns 85,350 shares of the company’s stock, valued at approximately $704,991. On Tuesday, shares of Dyax Corp. (NASDAQ:DYAX) advanced 2.38% to close the day at $8.81. Company return on investment (ROI) is -15.80% and its monthly performance is recorded as 42.02%.  Dyax Corp. (NASDAQ:DYAX) quarterly revenue growth is -4.91%.

Illumina, Inc (NASDAQ:ILMN) CFO Marc Stapley sold 1,422 shares of the stock on the open market in a transaction dated Monday, June 16th. The shares were sold at an average price of $169.25, for a total value of $240,673.50. Following the sale, the chief financial officer now directly owns 21,996 shares in the company, valued at approximately $3,722,823. Illumina, Inc. (NASDAQ:ILMN) stock performance was 0.28% in last session and finished the day at $169.85. Traded volume was 783,171.00million shares in the last session and the average volume of the stock remained 2.07million shares. The beta of the stock remained 0.54. Illumina, Inc. (NASDAQ:ILMN) insider ownership is 1.30%.